ROSEN, A TOP RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm Market News
Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm Market News
CLASS ACTION UPDATE for ABBV, AUPH and LICY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Limited Shareholders Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Volta, Embark, Lucid, and AbbVie and Encourages Investors to Contact the Firm Pharmaceutical Investing
Aurinia Pharmaceuticals Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
